Education
About Us
Working with TipRanks
Follow Us
Cellectar Biosciences (CLRB)
NASDAQ:CLRB
Earnings Data
Report Date
Oct 30, 2025TBA (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-2.53Last Year’s EPS
-12Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call highlighted significant progress in regulatory strategies and product pipeline advancements, especially with the potential accelerated approval path for Iopofosine I-131. However, the notable decrease in R&D and administrative expenses and an increased net loss indicate financial challenges. Overall, the sentiment is cautiously optimistic but tempered by financial concerns.Company Guidance
Regulatory Strategy for Iopofosine I-131
Cellectar plans to submit a New Drug Application (NDA) under an accelerated approval pathway for Iopofosine I-131 as a treatment for Waldenstrom's Macroglobulinemia (WM) with FDA breakthrough therapy designation and PRIME designation in Europe.
Financial Position and Funding
Cellectar raised nearly $10 million through recent financings and ended the quarter with $11 million in cash, adequate to fund operations into the second quarter of 2026.
Progress in Radiopharmaceutical Pipeline
Cellectar is on track to initiate Phase I trials for CLR 125 and CLR 225, targeting triple-negative breast cancer and solid tumors such as pancreatic cancer, respectively.
CLRB Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CLRB Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 14, 2025 | $4.42 | $4.42 | 0.00% |
May 13, 2025 | $7.92 | $7.20 | -9.09% |
Mar 13, 2025 | $9.50 | $8.99 | -5.37% |
Nov 18, 2024 | $55.80 | $53.10 | -4.84% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Cellectar Biosciences (CLRB) report earnings?
Cellectar Biosciences (CLRB) is schdueled to report earning on Oct 30, 2025, TBA (Confirmed).
What is Cellectar Biosciences (CLRB) earnings time?
Cellectar Biosciences (CLRB) earnings time is at Oct 30, 2025, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CLRB EPS forecast?
CLRB EPS forecast for the fiscal quarter 2025 (Q3) is -2.53.